LGC tightens pricing again on its KKR buyout loan
LGC, the UK life sciences company being bought by KKR, tightened price guidance on its €350m euro term loan ‘B’ again, after bringing forward its deadline.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts